# Protalix BioTherapeutics, Inc.: Form 8-K, filed Dec 31, 2024

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2024-12-31
- Accepted by EDGAR: Dec 31, 2024, 21:30 ET
- Period: 2024-12-27
- Accession: 0001558370-24-016505
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837024016505/plx-20241227x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837024016505/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837024016505/plx-20241227x8k.htm

Filed Dec 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-016505. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.